Macrophage Migration Inhibitory Factor and Stearoyl-CoA Desaturase 1: Potential Prognostic Markers for Soft Tissue Sarcomas Based on Bioinformatics Analyses

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Takahashi, Hiro ^a,b,c   Nakayama, Robert ^c,d   Hayashi, Shuhei ^e   Nemoto, Takeshi ^c,f   Murase, Yasuyuki ^g   Nomura, Koji ^g   Takahashi, Teruyoshi ^b   Kubo, Kenji ^b   Marui, Shigetaka ^b   Yasuhara, Koji ^b   Nakamura, Tetsuro ^b   Sueo, Takuya ^b   Takahashi, Anna ^b   Tsutsumiuchi, Kaname ^b   Ohta, Tsutomu ^c   Kawai, Akira ^h   Sugita, Shintaro ⁱ   Yamamoto, Shinjiro ^e   Kobayashi, Takeshi ^b   Honda, Hiroyuki ^g   Yoshida, Teruhiko ^c   Hasegawa, Tadashi ^h,i   more..

^a CHIBA UNIVERSITY   (Japan)

^b CHUBU UNIVERSITY   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^d KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e SOJO UNIVERSITY   (Japan)

^f TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^g NAGOYA UNIVERSITY   (Japan)

^h NATIONAL CANCER CENTER HOSPITAL   (Japan)

ⁱ SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DESATURASE 1; BIOLOGICAL MARKER; MACROPHAGE MIGRATION INHIBITION FACTOR; ACYL COENZYME A DESATURASE; ISOMERASE; MIF PROTEIN, HUMAN; SCD1 PROTEIN, HUMAN; TUMOR MARKER; TUMOR PROTEIN;

ADULT; ARTICLE; BIOINFORMATICS; CANCER PROGNOSIS; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MIF GENE; NUCLEOTIDE SEQUENCE; ONCOGENE; SCD1 GENE; SOFT TISSUE SARCOMA; SURVIVAL RATE; TUMOR GROWTH; BIOLOGY; BIOSYNTHESIS; CLINICAL TRIAL; DISEASE FREE SURVIVAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; METABOLISM; MIDDLE AGED; MORTALITY; SARCOMA; SOFT TISSUE TUMOR;

ADULT; COMPUTATIONAL BIOLOGY; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SARCOMA; SOFT TISSUE NEOPLASMS; STEAROYL-COA DESATURASE; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84887505879     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078250     Document Type: Article

References (75)

1. Gatta G, van der Zwan JM, Casali PG, Siesling S, Dei Tos AP, et al. (2011) Rare cancers are not so rare: the rare cancer burden in Europe. Eur J Cancer 47: 2493-2511. doi:10.1016/j.ejca.2011.08.008. PubMed: 22033323.
2. Gustafson P, (1994) Soft tissue sarcoma. Epidemiology and prognosis in 508 patients. Acta Orthop Scand Suppl 259: 1-31. PubMed: 8042499.
3. Fletcher CDM, Unni KK, Mertens F, editors (2002) Pathology and Genetics of Tumors of Soft Tissue and Bone. Lyon: IARC Press.
4. Nakayama R, Nemoto T, Takahashi H, Ohta T, Kawai A, et al. (2007) Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma. Mod Pathol 20: 749-759. doi:10.1038/modpathol.3800794. PubMed: 17464315.
5. Takahashi H, Kobayashi T, Honda H, (2005) Construction of robust prognostic predictors by using projective adaptive resonance theory as a gene filtering method. Bioinformatics 21: 179-186. doi:10.1093/bioinformatics/bth473. PubMed: 15308545.
6. Takahashi H, Honda H, (2005) A new reliable cancer diagnosis method using boosted fuzzy classifier with a SWEEP operator method. J Chem Eng Jpn 38: 763-773. doi:10.1252/jcej.38.763.
7. Takahashi H, Honda H, (2006) Prediction of peptide binding to major histocompatibility complex class II molecules through use of boosted fuzzy classifier with SWEEP operator method. J Biosci Bioeng 101: 137-141. doi:10.1263/jbb.101.137. PubMed: 16569609.
8. Kawamura T, Takahashi H, Honda H, (2008) Proposal of new gene filtering method, BagPART, for gene expression analysis with small sample. J Biosci Bioeng 105: 81-84. doi:10.1263/jbb.105.81. PubMed: 18295727.
9. Takahashi H, Aoyagi K, Nakanishi Y, Sasaki H, Yoshida T, et al. (2006) Classification of intramural metastases and lymph node metastases of esophageal cancer from gene expression based on boosting and projective adaptive resonance theory. J Biosci Bioeng 102: 46-52. doi:10.1263/jbb.102.46. PubMed: 16952836.
10. Takahashi H, Honda H, (2006) Lymphoma prognostication from expression profiling using a combination method of boosting and projective adaptive resonance theory. J Chem Eng Jpn 39: 767-771. doi:10.1252/jcej.39.767.
11. Takahashi H, Murase Y, Kobayashi T, Honda H, (2007) New cancer diagnosis modeling using boosting and projective adaptive resonance theory with improved reliable index. Biochem Eng J 33: 100-109. doi:10.1016/j.bej.2006.08.004.
12. Takahashi H, Nemoto T, Yoshida T, Honda H, Hasegawa T, (2006) Cancer diagnosis marker extraction for soft tissue sarcomas based on gene expression profiling data by using projective adaptive resonance theory (PART) filtering method. BMC Bioinformatics 7: 399. doi:10.1186/1471-2105-7-399. PubMed: 16948864.
13. Takahashi H, Takahashi A, Naito S, Onouchi H, (2012) BAIUCAS: a novel BLAST-based algorithm for the identification of upstream open reading frames with conserved amino acid sequences and its application to the Arabidopsis thaliana genome. Bioinformatics 28: 2231-2241. doi:10.1093/bioinformatics/bts303. PubMed: 22618534.
14. Kojima S, Iwasaki M, Takahashi H, Imai T, Matsumura Y, et al. (2011) Asymmetric leaves2 and Elongator, a histone acetyltransferase complex, mediate the establishment of polarity in leaves of Arabidopsis thaliana. Plant Cell Physiol 52: 1259-1273. doi:10.1093/pcp/pcr083. PubMed: 21700721.
15. Takahashi H, Honda H, (2006) Modified signal-to-noise: a new simple and practical gene filtering approach based on the concept of projective adaptive resonance theory (PART) filtering method. Bioinformatics 22: 1662-1664. doi:10.1093/bioinformatics/btl156. PubMed: 16632489.
16. Takahashi H, Iwakawa H, Nakao S, Ojio T, Morishita R, et al. (2008) Knowledge-based fuzzy adaptive resonance theory and its application to the analysis of gene expression in plants. J Biosci Bioeng 106: 587-593. doi:10.1263/jbb.106.587. PubMed: 19134556.
17. Takahashi H, Nakagawa A, Kojima S, Takahashi A, Cha BY, et al. (2012) Discovery of novel rules for G-quadruplex-forming sequences in plants by using bioinformatics methods. J Biosci Bioeng 114: 570-575. doi:10.1016/j.jbiosc.2012.05.017. PubMed: 22721688.
18. Takahashi H, Iwakawa H, Ishibashi N, Kojima S, Matsumura Y, et al. (2013) Meta-analyses of microarrays of Arabidopsis asymmetric leaves1 (as1), as2 and their modifying mutants reveal a critical role for the ETT pathway in stabilization of adaxial-abaxial patterning and cell division during leaf development. Plant Cell Physiol 54: 418-431. doi:10.1093/pcp/pct027. PubMed: 23396601.
19. Iwasaki M, Takahashi H, Iwakawa H, Nakagawa A, Ishikawa T, et al. (2013) Dual regulation of ETTIN (ARF3) gene expression by AS1-AS2, which maintains the DNA methylation level, is involved in stabilization of leaf adaxial-abaxial partitioning in Arabidopsis. Development 140: 1958-1969. doi:10.1242/dev.085365. PubMed: 23571218.
20. Nakagawa A, Takahashi H, Kojima S, Sato N, Ohga K, et al. (2012) Berberine enhances defects in the establishment of leaf polarity in asymmetric leaves1 and asymmetric leaves2 of Arabidopsis thaliana. Plant Mol Biol 79: 569-581. doi:10.1007/s11103-012-9929-7. PubMed: 22684430.
21. Sano M, Aoyagi K, Takahashi H, Kawamura T, Mabuchi T, et al. (2010) Forkhead box A1 transcriptional pathway in KRT7-expressing esophageal squamous cell carcinomas with extensive lymph node metastasis. Int J Oncol 36: 321-330. PubMed: 20043065.
22. Chiba Y, Mineta K, Hirai MY, Suzuki Y, Kanaya S, et al. (2013) Changes in mRNA stability associated with cold stress in Arabidopsis cells. Plant Cell Physiol 54: 180-194. doi:10.1093/pcp/pcs164. PubMed: 23220693.
23. Matsuo N, Mase H, Makino M, Takahashi H, Banno H, (2009) Identification of ENHANCER OF SHOOT REGENERATION 1-upregulated genes during in vitro shoot regeneration. Plant Biotechnol 26: 385-393. doi:10.5511/plantbiotechnology.26.385.
24. Takahashi H, Kaniwa N, Saito Y, Sai K, Hamaguchi T, et al. (2013) Identification of a candidate single-nucleotide polymorphism related to chemotherapeutic response through a combination of knowledge-based algorithm and hypothesis-free genomic data. J Biosci Bioeng (. (2013)) doi:10.1016/j.jbiosc.2013.05.021. PubMed: 23816762.
25. Takahashi H, Tomida S, Kobayashi T, Honda H, (2003) Inference of common genetic network using fuzzy adaptive resonance theory associated matrix method. J Biosci Bioeng 96: 154-160. doi:10.1016/S1389-1723(03)90118-6. PubMed: 16233501.
26. Yoshimura K, Mori T, Yokoyama K, Koike Y, Tanabe N, et al. (2011) Identification of alternative splicing events regulated by an Arabidopsis serine/arginine-like protein, atSR45a, in response to high-light stress using a tiling array. Plant Cell Physiol 52: 1786-1805. doi:10.1093/pcp/pcr115. PubMed: 21862516.
27. Kotooka N, Komatsu A, Takahashi H, Nonaka M, Kawaguchi C, et al. (2013) Predictive value of high-molecular weight adiponectin in subjects with a higher risk of the development of metabolic syndrome: From a population based 5-year follow-up data. Int J Cardiol 167: 1068-1070. doi:10.1016/j.ijcard.2012.10.066. PubMed: 23194783.
28. Yajima I, Kumasaka MY, Naito Y, Yoshikawa T, Takahashi H, et al. (2012) Reduced GNG2 expression levels in mouse malignant melanomas and human melanoma cell lines. Am J Cancer Res 2: 322-329. PubMed: 22679562.
29. Krockenberger M, Kranke P, Häusler S, Engel JB, Horn E, et al. (2012) Macrophage migration-inhibitory factor levels in serum of patients with ovarian cancer correlates with poor prognosis. Anticancer Res 32: 5233-5238. PubMed: 23225421.
30. Li J, Ding SF, Habib NA, Fermor BF, Wood CB, et al. (1994) Partial characterization of a cDNA for human stearoyl-CoA desaturase and changes in its mRNA expression in some normal and malignant tissues. Int J Cancer 57: 348-352. doi:10.1002/ijc.2910570310. PubMed: 7909540.
31. Liao B, Zhong BL, Li Z, Tian XY, Li Y, et al. (2010) Macrophage migration inhibitory factor contributes angiogenesis by up-regulating IL-8 and correlates with poor prognosis of patients with primary nasopharyngeal carcinoma. J Surg Oncol 102: 844-851. doi:10.1002/jso.21728. PubMed: 20872800.
32. Wang XB, Tian XY, Li Y, Li B, Li Z, (2012) Elevated expression of macrophage migration inhibitory factor correlates with tumor recurrence and poor prognosis of patients with gliomas. J Neuro Oncol 106: 43-51. doi:10.1007/s11060-011-0640-3. PubMed: 21725855.
33. Mantel N, (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50: 163-170. PubMed: 5910392.
34. Kaplan EL, Meier P, (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481. doi:10.1080/01621459.1958.10501452.
35. Watanabe I, Kurosawa N, Nishihira T, (1998) Establishment and characterization of a murine cell-line derived from malignant fibrous histiocytoma of A/Jackson mouse. Tohoku J Exp Med 184: 173-187. doi:10.1620/tjem.184.173. PubMed: 9591335.
36. Mosmann T, (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63. doi:10.1016/0022-1759(83)90303-4. PubMed: 6606682.
37. Bloom BR, Bennett B, (1966) Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153: 80-82. doi:10.1126/science.153.3731.80. PubMed: 5938421.
38. David JR, (1966) Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci U_S_A 56: 72-77. doi:10.1073/pnas.56.1.72. PubMed: 5229858.
39. George M, Vaughan JH, (1962) In vitro cell migration as a model for delayed hypersensitivity. Proc Soc Exp Biol Med 111: 514-521. doi:10.3181/00379727-111-27841. PubMed: 13947220.
40. Leech M, Metz C, Hall P, Hutchinson P, Gianis K, et al. (1999) Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum 42: 1601-1608. doi:10.1002/1529-0131(199908)42:8. PubMed: 10446857.
41. Lin SG, Yu XY, Chen YX, Huang XR, Metz C, et al. (2000) De novo expression of macrophage migration inhibitory factor in atherogenesis in rabbits. Circ Res 87: 1202-1208. doi:10.1161/01.RES.87.12.1202. PubMed: 11110779.
42. Lubetsky JB, Dios A, Han J, Aljabari B, Ruzsicska B, et al. (2002) The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents. J Biol Chem 277: 24976-24982. doi:10.1074/jbc.M203220200. PubMed: 11997397.
43. Dessein AF, Stechly L, Jonckheere N, Dumont P, Monté D, et al. (2010) Autocrine induction of invasive and metastatic phenotypes by the MIF-CXCR4 axis in drug-resistant human colon cancer cells. Cancer Res 70: 4644-4654. doi:10.1158/1538-7445.AM10-4644. PubMed: 20460542.
44. Meyer-Siegler KL, Iczkowski KA, Leng L, Bucala R, Vera PL, (2006) Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells. J Immunol 177: 8730-8739. PubMed: 17142775.
45. Winner M, Meier J, Zierow S, Rendon BE, Crichlow GV, et al. (2008) A novel, macrophage migration inhibitory factor suicide substrate inhibits motility and growth of lung cancer cells. Cancer Res 68: 7253-7257. doi:10.1158/0008-5472.CAN-07-6227. PubMed: 18794110.
46. Baron N, Deuster O, Noelker C, Stüer C, Strik H, et al. (2011) Role of macrophage migration inhibitory factor in primary glioblastoma multiforme cells. J Neurosci Res 89: 711-717. doi:10.1002/jnr.22595. PubMed: 21360573.
47. Piette C, Deprez M, Roger T, Noël A, Foidart JM, et al. (2009) The dexamethasone-induced inhibition of proliferation, migration, and invasion in glioma cell lines is antagonized by macrophage migration inhibitory factor (MIF) and can be enhanced by specific MIF inhibitors. J Biol Chem 284: 32483-32492. doi:10.1074/jbc.M109.014589. PubMed: 19759012.
48. Schrader J, Deuster O, Rinn B, Schulz M, Kautz A, et al. (2009) Restoration of contact inhibition in human glioblastoma cell lines after MIF knockdown. BMC Cancer 9: 464. doi:10.1186/1471-2407-9-464. PubMed: 20038293.
49. Liu H, Chen G, Zhang W, Zhu JY, Lin ZQ, et al. (2013) Overexpression of macrophage migration inhibitory factor in adenoid cystic carcinoma: correlation with enhanced metastatic potential. J Cancer Res Clin Oncol 139: 287-295. doi:10.1007/s00432-012-1330-z. PubMed: 23064787.
50. He XX, Chen K, Yang J, Li XY, Gan HY, et al. (2009) Macrophage migration inhibitory factor promotes colorectal cancer. Mol Med 15: 1-10. doi:10.2119/molmed.2008.00116. PubMed: 19009023.
51. Simpson KD, Templeton DJ, Cross JV, (2012) Macrophage migration inhibitory factor promotes tumor growth and metastasis by inducing myeloid-derived suppressor cells in the tumor microenvironment. J Immunol 189: 5533-5540. doi:10.4049/jimmunol.1201161. PubMed: 23125418.
52. Enoch HG, Catalá A, Strittmatter P, (1976) Mechanism of rat liver microsomal stearyl-CoA desaturase. Studies of the substrate specificity, enzyme-substrate interactions, and the function of lipid. J Biol Chem 251: 5095-5103. PubMed: 8453.
53. Castro LF, Wilson JM, Gonçalves O, Galante-Oliveira S, Rocha E, et al. (2011) The evolutionary history of the stearoyl-CoA desaturase gene family in vertebrates. BMC Evol Biol 11: 132. doi:10.1186/1471-2148-11-132. PubMed: 21595943.
54. Scaglia N, Igal RA, (2008) Inhibition of Stearoyl-CoA Desaturase 1 expression in human lung adenocarcinoma cells impairs tumorigenesis. Int J Oncol 33: 839-850. PubMed: 18813799.
55. Igal RA, (2010) Stearoyl-CoA desaturase-1: a novel key player in the mechanisms of cell proliferation, programmed cell death and transformation to cancer. Carcinogenesis 31: 1509-1515. doi:10.1093/carcin/bgq131. PubMed: 20595235.
56. Hess D, Chisholm JW, Igal RA, (2010) Inhibition of stearoylCoA desaturase activity blocks cell cycle progression and induces programmed cell death in lung cancer cells. PLOS ONE 5: e11394. doi:10.1371/journal.pone.0011394. PubMed: 20613975.
57. Nashed M, Chisholm JW, Igal RA, (2012) Stearoyl-CoA desaturase activity modulates the activation of epidermal growth factor receptor in human lung cancer cells. Exp Biol Med 237: 1007-1017. doi:10.1258/ebm.2012.012126. PubMed: 22946088.
58. Scaglia N, Chisholm JW, Igal RA, (2009) Inhibition of stearoylCoA desaturase-1 inactivates acetyl-CoA carboxylase and impairs proliferation in cancer cells: role of AMPK. PLOS ONE 4: e6812. doi:10.1371/journal.pone.0006812. PubMed: 19710915.
59. Roongta UV, Pabalan JG, Wang X, Ryseck RP, Fargnoli J, et al. (2011) Cancer cell dependence on unsaturated fatty acids implicates stearoyl-CoA desaturase as a target for cancer therapy. Mol Cancer Res 9: 1551-1561. doi:10.1158/1541-7786.MCR-11-0126. PubMed: 21954435.
60. Mason P, Liang B, Li L, Fremgen T, Murphy E, et al. (2012) SCD1 inhibition causes cancer cell death by depleting mono-unsaturated fatty acids. PLOS ONE 7: e33823. doi:10.1371/journal.pone.0033823. PubMed: 22457791.
61. Armstrong ME, Gantier M, Li L, Chung WY, McCann A, et al. (2008) Small interfering RNAs induce macrophage migration inhibitory factor production and proliferation in breast cancer cells via a double-stranded RNA-dependent protein kinase-dependent mechanism. J Immunol 180: 7125-7133. PubMed: 18490711.
62. Du X, Wang QR, Chan E, Merchant M, Liu J, et al. (2012) FGFR3 stimulates stearoyl CoA desaturase 1 activity to promote bladder tumor growth. Cancer Res 72: 5843-5855. doi:10.1158/0008-5472.CAN-12-1329. PubMed: 23019225.
63. Hagemann T, Wilson J, Kulbe H, Li NF, Leinster DA, et al. (2005) Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK. J Immunol 175: 1197-1205. PubMed: 16002723.
64. Han I, Lee MR, Nam KW, Oh JH, Moon KC, et al. (2008) Expression of macrophage migration inhibitory factor relates to survival in high-grade osteosarcoma. Clin Orthop Relat Res 466: 2107-2113. doi:10.1007/s11999-008-0333-1. PubMed: 18563508.
65. Rendon BE, Roger T, Teneng I, Zhao M, Al-Abed Y, et al. (2007) Regulation of human lung adenocarcinoma cell migration and invasion by macrophage migration inhibitory factor. J Biol Chem 282: 29910-29918. doi:10.1074/jbc.M704898200. PubMed: 17709373.
66. Sun B, Nishihira J, Suzuki M, Fukushima N, Ishibashi T, et al. (2003) Induction of macrophage migration inhibitory factor by lysophosphatidic acid: relevance to tumor growth and angiogenesis. Int J Mol Med 12: 633-641. PubMed: 12964047.
67. Sun B, Nishihira J, Yoshiki T, Kondo M, Sato Y, et al. (2005) Macrophage migration inhibitory factor promotes tumor invasion and metastasis via the Rho-dependent pathway. Clin Cancer Res 11: 1050-1058. PubMed: 15709171.
68. Morand EF, Leech M, Bernhagen J, (2006) MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis. Nat Rev Drug Discov 5: 399-410. doi:10.1038/nrd2029. PubMed: 16628200.
69. Zernecke A, Bernhagen J, Weber C, (2008) Macrophage migration inhibitory factor in cardiovascular disease. Circulation 117: 1594-1602. doi:10.1161/CIRCULATIONAHA.107.729125. PubMed: 18362243.
70. Bernhagen J, Krohn R, Lue H, Gregory JL, Zernecke A, et al. (2007) MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 13: 587-596. doi:10.1038/nm1567. PubMed: 17435771.
71. Igal RA, (2011) Roles of StearoylCoA Desaturase-1 in the Regulation of Cancer Cell Growth, Survival and Tumorigenesis. Cancers 3: 2462-2477. doi:10.3390/cancers3022462.
72. Cho Y, Crichlow GV, Vermeire JJ, Leng L, Du X, et al. (2010) Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast. Proc Natl Acad Sci U_S_A 107: 11313-11318. doi:10.1073/pnas.1002716107. PubMed: 20534506.
73. Rolan P, Gibbons JA, He L, Chang E, Jones D, et al. (2008) Ibudilast in healthy volunteers: safety, tolerability and pharmacokinetics with single and multiple doses. Br J Clin Pharmacol 66: 792-801. doi:10.1111/j.1365-2125.2008.03270.x. PubMed: 19032723.
74. Cross JV, Rady JM, Foss FW, Lyons CE, Macdonald TL, et al. (2009) Nutrient isothiocyanates covalently modify and inhibit the inflammatory cytokine macrophage migration inhibitory factor (MIF). Biochem J 423: 315-321. doi:10.1042/BJ20091170. PubMed: 19723024.
75. Oballa RM, Belair L, Black WC, Bleasby K, Chan CC, et al. (2011) Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia. J Med Chem 54: 5082-5096. doi:10.1021/jm200319u. PubMed: 21661758.